Joshua Roth

Joshua Roth serves as an Adjunct Assistant Professor in the Department of Pharmacy at the University of Washington School of Pharmacy and holds a concurrent position as Director of Global Value and Evidence for Oncology/Hematology at Pfizer, where he leads international health economics initiatives for cancer therapeutics.

His academic credentials include:

• Master of Health Administration (MHA) from University of Washington Department of Health Services
• PhD in Pharmaceutical Outcomes Research and Policy from University of Washington

Dr. Roth specializes in advanced comparative effectiveness research methodologies including observational study design, decision-analytic modeling, systematic reviews, and meta-analysis. His work focuses on evaluating benefit-risk profiles and economic value of pharmaceutical/diagnostic technologies in oncology, with particular emphasis on pharmacogenomic testing applications, cancer screening strategies, and alternative treatments for lung, breast, and prostate cancers. This research bridges clinical oncology with health policy through rigorous quantitative frameworks.

As an affiliate faculty member of the CHOICE Institute (Comparative Health Outcomes, Policy, and Economics Institute), he contributes to health services research addressing real-world evidence generation and policy implementation challenges in cancer care.